Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Naltrexone And Bupropion

A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program

Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 793

NCT00456521

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

X axis: threshold category. Y axis: participants reaching threshold, %.

66.3942.49
≥5%
41.4920.21
≥10%
≥15%
≥20%
Show as table
Arm≥5%≥10%≥15%≥20%
NB3266.39%41.49%n/rn/r
Placebo42.49%20.21%n/rn/r

Not shown

Every selected arm is drawn.